Literature DB >> 5071249

Cefazolin, a new semisynthetic cephalosporin antibiotic. V. Distribution of cefazolin- 14 C in mice and rats after parenteral administration.

J Kozatani, M Okui, K Noda, T Ogino, H Noguchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5071249     DOI: 10.1248/cpb.20.1105

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  5 in total

1.  Metabolic fate of [14C]SM-1652, a new antipseudomonal cephalosporin, after parenteral administration to rats.

Authors:  H Imasaki; Y Enjoji; H Matsui; R Kawai; S Kawamura; T Okuda
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

2.  Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.

Authors:  M F Rein; F B Westervelt; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

3.  Metabolic fate of SCE-129, a new antipseudomonal cephalosporin, after parenteral administration in rats and dogs.

Authors:  S Tanayama; K Yoshida; Y Kanai
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

4.  Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogs.

Authors:  S Tanayama; K Yoshida; K Adachi; T Kondo
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

5.  Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.

Authors:  K Yoshida; M Mitani; I Naeshiro; H Torii; S Tanayama
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.